Skip to main content

Biologic/Novel Rx

RN.podcast.resized_34.jpg
Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019.#1223  ALLN-346 a urate degrading enzyme in a pig model of goutL06 Emapalumab for treating MAS…
Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta.
Myosin Regulation May Contribute to Anti-TNF Therapy Response: Dr. Elaine Husni Dr. Husni highlights abstract #1769 as presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Panel Presentation: Rheumatoid Arthritis Drs. Jack Cush, Arthur Kavanaugh and Jonathan Kay discuss several rheumatoid arthritis studies presented at the 2019 ACR/ARP Annual Meeting in Atlanta. Abstracts discussed include abstract #1342, #1350, #1160, and more.
RN.podcast.resized_33.jpg
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.Study of ANA+ people without lupus or CTD shows that fatigue does not increase odds of having lupus or CTD. 1/3…
PSA2L_4.jpg
A cohort study of 97 patients with psoriatic arthritis (PsA) examined the prescribing practices in PsA, and found biologics are commonly initiated as the primary mode of therapy in outpatients with…
×